Santen Pharmaceutical Co., Ltd. held its 96th Annual General Meeting of Shareholders on June 25, 2008. The Meeting started at 10:00 a.m. and ended at 11:13 a.m. The number of shareholders attended was 168.
 

Matters reported	Business Report, Consolidated Financial Statements and Non-consolidated Financial Statements for the 96th Business Term (April 1, 2007 to March 31, 2008) Independent Auditors Report and Corporate Auditors Report on the consolidated Financial Statements for the 96th Business Term (April 1, 2007 to March 31, 2008)
Questions	Questions regarding oversea business, new drug candidates, manufacturing issues and medium-term management plan were answered.
Matters resolved	Five items of business as described below were all resolved. Resolution (PDF: 16KB)
Questions	Question regarding Proposal 2 (Appointment of Directors) and Proposal 4 (Issuance of the Rights to Subscribe for New Shares as Stock Option for the Directors) were answered.